- 圣湘生物 (688289)- 投资活动产生的现金流量

现金流分析步骤二:分析 投资活动 产生的现金流量

现金及等价物净增加额

1.6亿    ,0.2,0.9,-0.3,24.9,0.4,4.7,10.7,1.6
了解明细
期初现金及等价物余额

41.7亿    ,0.2,0.4,1.3,1.0,25.9,26.3,31.0,41.7
了解明细
期末现金及等价物余额

43.4亿    ,0.4,1.3,1.0,25.9,26.3,31.0,41.7,43.4
了解明细


经营活动现金流净额

-0.1亿    ,-0.6,0.1,0.2,26.4,18.8,25.6,0.4,-0.1
了解明细
投资活动现金流净额

0.3亿    ,-0.7,0.8,-0.9,-17.2,-11.1,-11.7,14.0,0.3
了解明细
筹资活动现金流净额

1.5亿    ,1.5,0,0.4,16.1,-6.9,-9.2,-3.7,1.5
了解明细
汇率变动对现金影响

-0.0亿    ,-0.0,-0.0,-0.0,-0.4,-0.3,-0.1,0.0,-0.0
了解明细


投资活动现金流出小计

15.6亿    ,1.2,1.7,2.3,38.3,82.6,127.6,79.4,15.6
了解明细
投资活动现金流入小计

15.9亿    ,0.5,2.5,1.3,21.2,71.4,115.9,93.4,15.9
了解明细
投资支付的现金

13.8亿    ,0.0,1.0,1.9,37.2,78.8,121.4,74.3,13.8
了解明细
收回投资收到的现金

16.1亿    ,0,1.0,1.3,20.9,70.5,115.0,92.3,16.1
了解明细
购建资产支付的现金

1.8亿    ,0.2,0.3,0.3,1.1,3.7,5.6,3.9,1.8
了解明细
出售资产收回的现金

0.0亿    ,0.0,0.0,0.0,0.1,0.2,0.0,0.0,0.0
了解明细
取得子公司支付的现金

0亿    ,0,0,0,0,0,0.1,1.1,0
了解明细
处置子公司收到的现金

-0.6亿    ,0,0,0,0,0,0,0,-0.6
了解明细
支付其他投资有关的现金

0.0亿    ,0.9,0.4,0.0,-0.0,0.0,0.5,-0.0,0.0
了解明细
收到其他投资有关的现金

0亿    ,0.5,1.5,0.0,0,0.0,0,0.4,0
了解明细
取得投资收益的现金

0.3亿    ,0,0.0,0.0,0.2,0.8,0.9,0.7,0.3
了解明细